A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection
Clinical trial NCT06717932 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06717932
- Sponsor
- CorrectSequence Therapeutics Co., Ltd
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-15
- Primary completion
- 2039-11-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.